"Recurrence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The return of a sign, symptom, or disease after a remission.
Descriptor ID |
D012008
|
MeSH Number(s) |
C23.550.291.937
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recurrence".
Below are MeSH descriptors whose meaning is more specific than "Recurrence".
This graph shows the total number of publications written about "Recurrence" by people in this website by year, and whether "Recurrence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 10 | 10 |
1995 | 0 | 22 | 22 |
1996 | 0 | 13 | 13 |
1997 | 0 | 21 | 21 |
1998 | 0 | 20 | 20 |
1999 | 0 | 27 | 27 |
2000 | 0 | 21 | 21 |
2001 | 0 | 23 | 23 |
2002 | 0 | 19 | 19 |
2003 | 0 | 19 | 19 |
2004 | 0 | 17 | 17 |
2005 | 0 | 25 | 25 |
2006 | 0 | 28 | 28 |
2007 | 0 | 19 | 19 |
2008 | 0 | 32 | 32 |
2009 | 0 | 22 | 22 |
2010 | 0 | 38 | 38 |
2011 | 0 | 38 | 38 |
2012 | 0 | 37 | 37 |
2013 | 0 | 33 | 33 |
2014 | 0 | 32 | 32 |
2015 | 0 | 32 | 32 |
2016 | 1 | 39 | 40 |
2017 | 0 | 26 | 26 |
2018 | 0 | 28 | 28 |
2019 | 0 | 38 | 38 |
2020 | 0 | 34 | 34 |
2021 | 0 | 26 | 26 |
2022 | 0 | 15 | 15 |
2023 | 0 | 21 | 21 |
2024 | 5 | 9 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recurrence" by people in Profiles.
-
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas. Blood Adv. 2024 Jul 09; 8(13):3507-3518.
-
Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry. Europace. 2024 Jul 02; 26(7).
-
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL. Blood Adv. 2024 Jun 25; 8(12):3226-3236.
-
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations. Pediatr Blood Cancer. 2024 Aug; 71(8):e31075.
-
Impact of Poverty on Stroke Recurrence: A Population-Based Study. Neurology. 2024 Jun 11; 102(11):e209423.
-
Twenty years of embolization for acute lower gastrointestinal bleeding: a meta-analysis of rebleeding and ischaemia rates. Br J Radiol. 2024 May 07; 97(1157):920-932.
-
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model. J Hematol Oncol. 2024 May 03; 17(1):28.
-
Gas and Bloat in Female Patients after Antireflux Procedures: Analysis of 934 Cases. J Am Coll Surg. 2024 Jul 01; 239(1):18-29.
-
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood Adv. 2024 Apr 23; 8(8):2020-2029.
-
Management of symptomatic, asymptomatic, and recurrent hiatal hernia: a systematic review and meta-analysis. Surg Endosc. 2024 Jun; 38(6):2917-2938.